Methods for detecting random off-target effects of single-base editing systems
By introducing a CRISPR system orthogonal to the single-base editing system in cells, a stable single-stranded DNA region is generated, and the random off-target effect of the single-base editing system is detected by high-throughput sequencing, which solves the detection problems in the prior art. It achieves simple, low-cost and efficient detection effects.
Patent Information
- Application Number
- CN202180019218.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-03-04
- Filing Date
- 2021-03-04
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2041-03-04
AI Technical Summary
The existing single-base editing system will produce unpredictable random off-target phenomena within the genome range, resulting in genome-wide off-target effects. The current detection methods are expensive and have a long period of time, so it is impossible to detect multiple single-base editing systems with high throughput. random off-target effect.
By introducing a CRISPR system orthogonal to the single-base editing system to be detected into the cells, a stable single-stranded DNA region is generated, so that the random off-target effect of the single-base editing system can be detected through high-throughput sequencing, using Trans-ssDNA amplicon deep sequencing (TA-AS) method.
It realizes the simple and low-cost and efficient detection of random off-target effects of single-base editing systems, and improves the sensitivity and accuracy of detection.
Smart Images

Figure BDA0003833141910000051 
Figure BDA0003833141910000061 
Figure HDA0003833141920000011
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of gene editing. Specifically, the present invention relates to a method for rapid high-throughput detection of random off-target effects of a single-base editing system in the whole genome. Background of the Invention
[0003] Genome editing technology is a genetic engineering technology based on artificial nucleases to modify the genome in a targeted manner, and it plays an increasingly powerful role in agricultural and medical research. Clustered regularly interspaced short palindromic repeats / CRISPR (associated, CRISPR) is currently the most widely used genome editing tool. Under the guidance of artificially designed guide RNA, Cas proteins can target any position in the genome.
[0004] The single-base editing system is a new gene editing technology developed based on the CRISPR system. It is divided into the cytosine single-base editing system and the adenine single-base editing system. Cytosine deaminase and adenine deaminase are fused with the Cas9 single-stranded nickase, respectively. Under the targeting action of the guide RNA, the Cas9 single-stranded nickase produces a single-stranded DNA region. Therefore, the deaminase can efficiently deaminate the C or A nucleotides on the single-stranded DNA at the targeted position, turning them into U bases and I bases, which are then repaired to T bases or G bases during the cell's own repair process. However, the cytosine single-base editing system has been found to produce unpredictable off-target phenomena within the genome, which is most likely due to the overexpression of cytosine deaminase in the genome and the random deamination phenomenon in the highly transcriptionally active regions of the genome. The genome-wide off-target phenomenon has greatly affected the use of the cytosine single-base editing system.
[0005] To date, the only way to evaluate the off-target effects of single-base editing systems is to use whole-genome sequencing technology to sequence a large number of cells or biological individuals that have undergone single-base editing, and count the number of point mutations across the entire genome to evaluate the random off-target effects of the single-base editing system across the genome. However, this method is expensive, has a long experimental cycle, and cannot detect the random off-target effects of multiple single-base editing systems across the genome with high throughput.
[0006] The present invention still requires a simple, low-cost method for detecting random off-target effects of single-base editing systems.
[0007] Brief description of the invention
[0008] The inventors discovered that by co-transfecting a single-stranded region with a single-base editor to be identified and another CRISPR system that is orthogonal to the single-base editing system, a long-term stable single-stranded region can be generated in the genome, so that the single-base editor that can randomly act on the single-stranded DNA region can deaminize the target base in the single-stranded region. The random off-target effect of the single-base editing system can be efficiently and conveniently detected by amplicon high-throughput sequencing. This method is called the Trans-ssDNA amplicon deep sequencing (TA-AS) method. BRIEF DESCRIPTION OF THE DRAWINGS
[0010] Figure 1 , schematic diagram of orthogonal system detection carrier.
[0011] Figure 2 , verification of the TA-AS system by rice protoplast transformation.
[0012] Figure 3 , schematic diagram of BE3 vector.
[0013] Figure 4 , TA-AS method to detect the off-target effects of different single-base editing systems.
[0014] Figure 5 , whole genome sequencing to detect the off-target effects of five single-base editing systems.
[0015] Figure 6 , regression analysis of whole genome sequencing results and TA-AS results. DETAILED DESCRIPTION OF THE INVENTION
[0017] In one aspect, the present invention provides a method for detecting stochastic off-target effects of a base editing system, the method comprising:
[0018] a) introducing the base editing system to be tested into a cell or an organism;
[0019] b) introducing into a cell or organism a detection CRISPR system targeting at least one detection target site in the genome, wherein the detection CRISPR system is capable of forming a single-stranded DNA region at the at least one detection target site, and its guide RNA is incompatible with the guide RNA of the base editing system to be detected;
[0020] c) extracting nucleic acid from the cell or organism and amplifying the sequence of the at least one detection target site, and sequencing the amplicon; and
[0021] d) determining the nucleotide mutation at the at least one detection target site.
[0022] In some embodiments, the detection of nucleotide mutations in the at least one detection target site indicates that the base editing system to be detected has off-target. The amount of nucleotide mutations detected in the at least one detection target site represents the degree of off-target, and the more nucleotide mutations detected represent the higher the degree of off-target.
[0023] The base editing system to be detected may include a base editor to be detected or an expression construct comprising its coding sequence, and / or its corresponding guide RNA (gRNA) or an expression construct comprising its coding sequence. In some embodiments, the base editing system to be detected in step a) only includes a base editor to be detected or an expression construct comprising its coding sequence.
[0024] As used herein, "base editor" refers to a fusion protein comprising a CRISPR effector protein and a deaminase. Depending on the deaminase, base editors can be divided into cytosine base editors and adenine base editors. In some preferred embodiments, the base editing system to be tested of the present invention comprises a cytosine base editor.
[0025] The cytosine base editor is typically a fusion protein comprising a CRISPR effector protein and a cytosine deaminase. The cytosine deaminase in the base editor can convert the cytidine deamination of the single-stranded DNA produced in the formation of the CRISPR effector protein-guide RNA-target DNA complex into U, and then achieve the base replacement of C to T by base mismatch repair. In some embodiments, the cytosine base editor also includes a uracil DNA glycosylase inhibitor (UGI). In cells, uracil DNA glycosylase catalyzes the removal of U from DNA and initiates base excision repair (BER), resulting in the repair of U:G to C:G. Therefore, without being limited by any theory, the inclusion of a uracil DNA glycosylase inhibitor (UGI) in the cytosine base editor will be able to increase the efficiency of C to T base editing.
[0026] Examples of cytosine deaminases include, but are not limited to, for example, APOBEC1 deaminases, activation-induced cytidine deaminases (AID), APOBEC3G, CDA1, human APOBEC3A deaminases, or functional variants thereof. In some embodiments, the cytosine deaminases are human APOBEC3A or functional variants thereof. In some embodiments, the cytosine deaminases are APOBEC1 or functional variants thereof. In some specific embodiments, the cytosine deaminases include the amino acid sequences of SEQ ID NOs: 7-10.
[0027] However, the methods of the present invention can be used to test the off-target effects of base editors comprising various cytosine deaminase variants.
[0028] As used herein, the term "CRISPR effector protein" generally refers to nucleases present in naturally occurring CRISPR systems, as well as modified forms thereof, variants thereof, catalytically active fragments thereof, etc. The term encompasses any effector protein based on the CRISPR system that is capable of achieving gene targeting (e.g., gene editing, gene targeting regulation, etc.) in cells.
[0029] Examples of "CRISPR effector proteins" include Cas9 nucleases or variants thereof. The Cas9 nuclease may be a Cas9 nuclease from a different species, such as spCas9 from Streptococcus pyogenes (S. pyogenes) or SaCas9 derived from Staphylococcus aureus (S. aureus). "Cas9 nuclease" and "Cas9" are used interchangeably herein to refer to an RNA-guided nuclease comprising a Cas9 protein or a fragment thereof (e.g., a protein comprising an active DNA cleavage domain of Cas9 and / or a gRNA binding domain of Cas9). Cas9 is a component of the CRISPR / Cas (clustered regularly interspaced short palindromic repeats and related systems) genome editing system that can target and cut a DNA target sequence under the guidance of a guide RNA to form a DNA double-strand break (DSB).
[0030] Examples of "CRISPR effector proteins" may also include Cpf1 nucleases or variants thereof, such as highly specific variants. The Cpf1 nuclease may be a Cpf1 nuclease from a different species, such as a Cpf1 nuclease from Francisella novicida U112, Acidaminococcus sp. BV3L6, and Lachnospiraceae bacterium ND2006.
[0031] In some embodiments, the CRISPR effector protein of the base editor of the present invention is an acidase-inactivated CRISPR effector protein. In some embodiments, the CRISPR effector protein of the base editor of the present invention is a CRISPR effector protein with nickase activity. In some embodiments, the CRISPR effector protein of the base editor of the present invention is a Cas9 nickase. In some preferred embodiments, in some embodiments, the CRISPR effector protein of the base editor of the present invention is a nickase form (nSpCas9) of SpCas9 from Streptococcus pyogenes (S.pyogenes). For example, the nSpCas9 comprises the amino acid sequence shown in SEQ ID NO: 1. In some embodiments, the CRISPR effector protein of the base editor of the present invention is a nickase form (nSaCas9) of SaCas9 from Staphylococcus aureus (S.aureus). For example, the nSaCas9 comprises the amino acid sequence shown in SEQ ID NO: 2.
[0032] The detection CRISPR system of the present invention may include a CRISPR effector protein or an expression construct comprising a nucleotide sequence encoding the same, and a guide RNA targeting at least one genomic target site (detection target site) or an expression construct comprising a nucleotide sequence encoding the same.
[0033] In some embodiments, the CRISPR effector protein of the detection CRISPR system of the present invention is an acidase-inactivated CRISPR effector protein. In some embodiments, the CRISPR effector protein of the detection CRISPR system of the present invention is a CRISPR effector protein with nickase activity. In some embodiments, the CRISPR effector protein of the detection CRISPR system of the present invention is a Cas9 nickase. In some preferred embodiments, in some embodiments, the CRISPR effector protein of the detection CRISPR system of the present invention is a nickase form (nSpCas9) of SpCas9 from Streptococcus pyogenes (S.pyogenes). For example, the nSpCas9 comprises the amino acid sequence shown in SEQ ID NO: 1. In some embodiments, the CRISPR effector protein of the detection CRISPR system of the present invention is a nickase form (nSaCas9) of SaCas9 from Staphylococcus aureus (S.aureus). For example, the nSaCas9 comprises the amino acid sequence shown in SEQ ID NO: 2.
[0034] Incompatibility of the guide RNA of the testing CRISPR system with the base editing system to be tested means that the testing CRISPR system cannot use the guide RNA of the base editing system to be tested, and the base editing system to be tested cannot use the guide RNA of the testing CRISPR system. This depends on the different CRISPR effector proteins used in the system.
[0035] In some embodiments, the CRISPR effector protein in the detection CRISPR system and the CRISPR effector protein in the base editor to be detected are of different origins, and thus their guide RNAs are incompatible.
[0036] In some embodiments, the CRISPR effector protein in the detection CRISPR system is derived from SaCas9 of Staphylococcus aureus (S. aureus), and its corresponding guide RNA comprises the scaffold sequence shown in SEQ ID NO:5.
[0037] In some embodiments, the CRISPR effector protein in the detection CRISPR system is derived from SpCas9 of Streptococcus pyogenes (S. pyogenes), and its corresponding guide RNA comprises the scaffold sequence shown in SEQ ID NO:11.
[0038] In some embodiments, the CRISPR effector protein in the base editor to be detected is derived from SpCas9, for example, nSpCas9 (SEQ ID NO: 1), and the CRISPR effector protein in the detection CRISPR system is derived from SaCas9, for example, nSaCas9 (SEQ ID NO: 2). In some embodiments, the CRISPR effector protein in the detection CRISPR system is derived from SpCas9, for example, nSpCas9 (SEQ ID NO: 1), and the CRISPR effector protein in the base editor to be detected is derived from SaCas9, for example, nSaCas9 (SEQ ID NO: 2).
[0039] In some embodiments, the detection CRISPR system of the present invention comprises a plurality of guide RNAs targeting a plurality of genomic detection target sites or an expression construct comprising a nucleotide sequence encoding the guide RNA. In some embodiments, the base editing system to be detected of the present invention does not comprise a guide RNA or an expression construct thereof, or comprises a guide RNA but targets a detection target site different from that of the detection CRISPR system.
[0040] In some embodiments, the cell is a eukaryotic cell, such as a mammalian cell or a plant cell. Alternatively, the organism is a eukaryotic organism, such as a mammal or a plant.
[0041] In another aspect, the present invention also relates to a kit for use in the above method of the present invention. The kit comprises at least the detection CRISPR system of the present invention, and optionally amplification primers of the target site targeted by the detection CRISPR system. Example
[0042] Example 1: Development of TA-AS system
[0043] It is reported that the guide RNA backbones between many CRISPR systems are orthogonal, that is, the nuclease in the CRISPR system can only form a protein-RNA complex with the guide RNA of the system to perform its function. The inventors used nSpCas9 (Cas9 from Streptococcus pyogenes, a nickase variant with a D10A point mutation) as an example of a single-base editing system, and tested whether the orthogonal nSaCas9 (Cas9 from Staphylococcus aureus, a nickase variant with a D10A point mutation), dSaCas9 (Cas9 from Staphylococcus aureus, an inactivated variant with D10A and N580A point mutations) and dLbCpf1 (Cpf1 protein from Lachnospiraceae, an inactivated variant with a D832A point mutation) can create a single-stranded DNA region for the cytosine single-base editing system to produce off-target.
[0044] 1.1. Target fragment and vector construction
[0045] Table 1 below shows the targets used by the orthogonal CRISPR systems. The PAM sequence is marked in bold, and the C base in the target site is underlined. The OsCDC48-SaT1 and OsNRT1.1B-SaT1 targets are used for testing the nSaCas9 and dSaCas9 systems, and the OsEPSPS-Cpf1T1 and OsPDS-Cfp1T1 targets are used for testing the LbCpf1 system.
[0046] Table 1.
[0047]
[0048] The single-base editing system to be tested in this experiment is the A3A-BE3 system, that is, the base editor is a fusion protein composed of human APOBEC3A deaminase, nSpCas9 (Streptococcus pyogenes), UGI (uracil glycosylase inhibitor) and NLS (nuclear localization signal), its expression vector is pA3A-BE3, and its target vector is pSp-sgRNA. The other three CRISPR systems are denoted as pnSaCas9 and pSa-sgRNA, pdSaCas9 and pSa-sgRNA target vector, and pdLbCpf1 and Lb-crRNA. The vector structures are as follows Figure 1 shown.
[0049] 1.2. Validation of the TA-AS system by rice protoplast transformation
[0050] The A3A-BE3 vector was co-transformed into rice protoplasts with the following combinations: pnSaCas9 / pSa-sgRNA-OsCDC48-SaT1, pnSaCas9 / pSa-sgRNA-OsNRT1.1B-SaT1, pdSaCas9 / pSa-sgRNA-OsCDC48-SaT1, pdSaCas9 / pSa-sgRNA-OsNRT1.1B-SaT1, pdLbCpf1 / pLb-crRNA-OsEPSPS-Cpf1T1, and pdLbCpf1 / pLb-crRNA-OsPDS-Cfp1T1, respectively.
[0051] After high-throughput sequencing of the target site amplicons, it was found that A3A-BE3 without editing targets had a high level of C to T single-base editing at the nSaCas9-targeted OsCDC48-SaT1 and OsNRT1.1B-SaT1 targets, while no obvious single-base editing was detected in the other two treatment groups, and no single-base editing was detected in the untreated group (Untreated). Figure 2 ). This indicates that nSaCas9 can generate persistent and stable ssDNA regions in plants for high-throughput detection of random off-target effects of the cytosine single-base editing system.
[0052] Example 2: Detection of off-target activity of existing single-base editing systems by target site amplicon sequencing
[0053] Using the TA-AS system, the random off-target effects of the reported cytosine single-base editing systems BE3, YEE-BE3, RK-BE3, A3A-BE3 and eA3A-BE3 were analyzed.
[0054] 2.1. Target fragment and vector construction
[0055] The vectors involved in this experiment are all single-base editing systems based on the BE3 single-base editor backbone. The rAPOBEC1 deaminase in the BE3 vector is replaced with other deaminases to obtain different single-base editors. The vector backbone of BE3 is as follows: Figure 3 As shown, RK and YEE represent the R33AK34A variant and W90YR126ER132E variant of rat rAPOBEC1 deaminase, and eA3A represents the N57G variant of human hAPOBEC3A.
[0056] The targets involved in this experiment include those in Table 2 below. The PAM sequence is marked in bold, and the C base in the target site is underlined. OsAAT1-T1, OsACTG-T1, OsEV-T1 and OsCDC48-T1 are the target sites used by the cytosine single-base editing system, and OsCDC48-SaT1, OsDEP1-SaT1, OsDEP1-SaT2 and OsNRT1.1B-SaT1 are the off-target detection targets used by nSaCas9.
[0057] Table 2.
[0058]
[0059] 2.2. Detection of off-target activities of multiple single-base editing systems using rice protoplast transformation
[0060] In this experiment, different single-base editing system vectors, pnSaCas9 vectors and pSa-sgRNA vectors were co-transformed into rice protoplasts to detect the off-target efficiency of different single-base editing systems. Figure 4 The A3A-BE3 system showed the highest random off-target effect, followed by BE3 and eA3A, and the YEE and RK systems had almost no random off-target effect.
[0061] Example 3: Verification of the accuracy of the TA-AS method by whole genome sequencing of individual plants
[0062] The use of plant whole genome sequencing to evaluate genome-wide off-target effects is currently the most direct and accurate detection method. Using Agrobacterium-mediated transformation of different single-base editing system expression vectors, rice T0 generation regenerated plants overexpressing the single-base editing systems BE3, YEE-BE3, RK-BE3, A3A-BE3, and eA3A-BE3 were obtained, and plants only transformed by Agrobacterium were used as the control group (Control). The plants were sequenced throughout their genomes, and it was found that there was no significant difference in the number of small fragment insertions and deletions (Indels) in the five groups of overexpressed rice genomes ( Figure 5 a), but in terms of the total number of nucleotide variations (All SNVs), there were significant differences between the BE3 and A3A-BE3 treatment groups and the Control group, with an additional 102 and 316 SNVs, respectively, compared with the Control group. Figure 5 b). In terms of the number of CtoT nucleotide variations (C to T SNVs), BE3-BE3, A3A-BE3, and eA3A-BE3 were significantly different from the Control group, generating an additional 69 and 243 C to T SNVs, respectively. Figure 5c). In contrast, no obvious off-target effects were detected for YEE-BE3 and RK-BE3 ( Figure 5 ). In addition, the average values of C to T SNVs of the five single-base editing system treatment groups in this experiment were compared with Figure 4 The correlation analysis of off-target effects detected by the TA-AS system showed that the TA-AS method had a significant correlation with the whole genome sequencing results ( Figure 6 ). For these five single-base editing systems, the TA-AS method and the whole genome sequencing method showed the same experimental results, which shows that this method has high sensitivity and accuracy and can be used to detect the random off-target effects of single-base editing systems in a high-throughput and simple manner.
[0063] Sequence Listing
[0064] SEQ ID NO:1 nSpCas9 amino acid sequence
[0065]
[0066] SEQ ID NO:2 nSaCas9 amino acid sequence
[0067]
[0068] SEQ ID NO:3 dSaCas9 amino acid sequence
[0069]
[0070] SEQ ID NO:4 dLbCpf1 amino acid sequence
[0071]
[0072] SEQ ID NO:5 Sa-sgRNA scaffold sequence
[0073] GUUUUAGUACUCUGGAAACAGAAUCUACUAAAACAAGGCAAAAUGCCGUGUUUAUCUCGUCAACUUGUUGGCGAGA
[0074] SEQ ID NO:6 Lb-crRNA scaffold sequence
[0075] UAAUUUCUACUaagUGUAGAU
[0076] SEQ ID NO:7 hA3A deaminase
[0077] EASPASGPRHLMDPHIFTSNFNNGIGRHKTYLCYEVERLDNGTSVKMDQHRGFLHNQAKNLLCGFYGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFKHCWDTFVDHQGCPFQPWDGLDEHSQALSGRLRAILQNQGNSGSETPGTSESATPES
[0078] SEQ ID NO:8 rAPOBEC1-RK deaminase
[0079] SSETGPVAVDPTLRRRIEPHEFEVFFDPRELAAETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSWSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPRNRQGLRDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLK
[0080] SEQ ID NO:9 rAPOBEC1-YEE deaminase
[0081] SSETGPVAVDPTLRRRIEPHEFEVFFDPRELRKETCLLYEINWGGRHSIWRHTSQNTNKHVEVNFIEKFTTERYFCPNTRCSITWFLSYSPCGECSRAITEFLSRYPHVTLFIYIARLYHHADPENRQGLEDLISSGVTIQIMTEQESGYCWRNFVNYSPSNEAHWPRYPHLWVRLYVLELYCIILGLPPCLNILRRKQPQLTFFTIALQSCHYQRLPPHILWATGLK
[0082] SEQ ID NO:10 rAPOBEC1-eA3A deaminase
[0083] EASPASGPRHLMDPHIFTSNFNNGIGRHKTYLCYEVERLDNGTSVKMDQHRGFLHGQAKNLLCGFYGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIFAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFKHCWDTFVDHQGCPFQPWDGLDEHSQALSGRLRAILQNQGNSGSETPGTSESATPES
[0084] SEQ ID NO:11 SpsgRNA scaffold sequence
[0085] GUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGC
Claims
1. A method for detecting random off-target effects of a base editing system, the method comprising: a) introducing a base editing system to be tested into a eukaryotic cell or a eukaryotic organism; wherein the base editing system to be tested comprises a base editor to be tested or an expression construct comprising a base editor coding sequence to be tested; and the base editor is a fusion protein comprising a CRISPR effector protein and a deaminase; b) introducing into a eukaryotic cell or eukaryotic organism a detection CRISPR system targeting at least one detection target site in the genome, wherein the detection CRISPR system is capable of forming a single-stranded DNA region at the at least one detection target site, and the CRISPR effector protein in the detection CRISPR system and the CRISPR effector protein in the base editor to be detected are of different origins, so that their guide RNAs are incompatible; the CRISPR effector protein is a Cas9 nickase; c) extracting nucleic acid from the eukaryotic cell or eukaryotic organism and amplifying the sequence of the at least one detection target site, and sequencing the amplicon; and d) determining a nucleotide mutation at the at least one detection target site. The method according to claim 1 , wherein the deaminase is cytosine deaminase.
3. The method according to claim 2, wherein the cytosine deaminase is selected from APOBEC1 deaminase, activation-induced cytidine deaminase AID, APOBEC3G, CDA1, human APOBEC3A deaminase, or functional variants thereof, and the cytosine deaminase comprises the amino acid sequence of SEQ ID NO: 7-10.
4. The method according to claim 1, wherein the CRISPR effector protein of the base editor is from Streptococcus pyogenes ( S. pyogenes ) is a nickase nSpCas9 form of SpCas9, which comprises the amino acid sequence shown in SEQ ID NO:
1.
5. The method according to claim 1, wherein the CRISPR effector protein of the base editor is from Staphylococcus aureus ( S. aureus ) The nickase nSaCas9 form of SaCas9 comprises the amino acid sequence shown in SEQ ID NO:
2.
6. The method according to claim 1, wherein the CRISPR effector protein of the detection CRISPR system is a nickase nSpCas9 form of SpCas9 from Streptococcus pyogenes (S. pyogenes), which comprises the amino acid sequence shown in SEQ ID NO:
1.
7. The method according to claim 1, wherein the CRISPR effector protein for detecting the CRISPR system is a nickase nSaCas9 form from Staphylococcus aureus (S. aureus) SaCas9, and the nSaCas9 comprises the amino acid sequence shown in SEQID NO:
2.
8. According to the method according to any one of claims 1-7, the CRISPR effector protein in the base editor is derived from SpCas9, including nSpCas9, and the CRISPR effector protein in the detection CRISPR system is derived from SaCas9, including nSaCas9.
9. The method according to any one of claims 1-7, wherein the CRISPR effector protein in the detection CRISPR system is derived from SpCas9, including nSpCas9, and the CRISPR effector protein in the detection CRISPR system is derived from SaCas9, including nSaCas9.
10. The method according to any one of claims 1-7, wherein the detection CRISPR system comprises a plurality of guide RNAs targeting a plurality of genomic detection target sites or an expression construct comprising a nucleotide sequence encoding the guide RNA.
11. According to the method according to any one of claims 1-7, the base editing system to be detected does not contain a guide RNA or its expression construct, or contains a guide RNA but targets a detection target site different from that of the detection CRISPR system.
12. The method according to any one of claims 1 to 7, wherein the eukaryotic cell comprises a mammalian cell or a plant cell; and the eukaryotic organism comprises a mammal or a plant.
